Drug discovery

#CRO #Drug development #Drug discovery #Genomics

CROs: Drug discovery expertise on hand  

Listen to this article on the DDW Podcast: Lu Rahman asks Laura Hinton, Operations Director at Gentronix, to offer some insight into the contract research organisation (CRO) market and how Gentronix is making its presence known in this sector.  Gentronix is a specialist contract research organisation (CRO) based in the UK, focused on delivering… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Collaboration #Drug discovery #Oncology

Drug discovery collaboration to progress inhibitor project  

Domainex has supported the collaboration between Queen’s University Belfast (UK) and Ipsen to research, develop, manufacture and commercialise FLIP inhibitors – a programme that Domainex has supported since its inception.  Background  At the start of the project, Domainex conducted a LeadBuilder virtual screen that generated the initial hit matter. Read More

#News

#Drug discovery #Drug research #Drug targets

This week in drug discovery (31 January – 4 February) 

News round-up by DDW’s Megan Thomas for 31 January – 4 February, 2022  This week, DDW’s Megan Thomas has rounded up five stories that highlight the impact of research, breakthroughs, agreements and trials in the drug discovery world.  1. Researchers discover way to disarm… Read More

#News

#Autoimmune disease #Drug discovery #Research

Study profiles side-effects linked to common immunosuppressant 

New research led by scientists from the UK’s University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) has profiled the side effects of methotrexate – a common drug used to treat arthritis and other autoimmune diseases.   The findings  The authors hope their findings –… Read More

#News

#Drug discovery #Eye health #iPSC #Ophthalmology #Partnership

Evotec enters ophthalmology drug discovery partnership 

Evotec has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell (iPSC)-based disease modelling for ophthalmologic disorders.   Context   Millions of people are affected by vision-related diseases worldwide, and there is a high unmet need for novel therapeutic solutions. … Read More

#News

Bacteria
#Drug development #Drug discovery #Events #Microbiome #Therapeutics

Take aways from Microba’s presentation at European summit

Microba Life Sciences, a precision microbiome science company based in Australia, showcased its therapeutic platform and discovery platform for the identification of novel microbial signatures at Microbiome Movement, a European drug development summit, on January 27.  The event  The event brought together researchers from the biopharmaceutical… Read More

#News

Laboratory mouse
#Biosciences #Drug discovery #Podcast

How to accelerate mouse model generation – podcast

The latest DDW Sitting Down With sponsored podcast features Dominque Bröhl and Evert-Jan Uringa, Scientific Program Managers at Taconic Biosciences, who discuss how mouse model generation can be accelerated without any loss of quality. They offer insight into the latest developments, innovation and challenges in mouse model generation, how… Read More

#News

#Collaboration #Comment #Drug discovery #Lab automation #SLAS2022

Comment: SLAS’ strength is collaboration 

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. As we all look forward to the expertise at the event, Jill Hronek, Director of Marketing and Communications at SLAS, comments that collaboration has always… Read More

#Editor's Choice #Exclusive Content #News

#AI / data analytics / healthtech / informatics #Drug discovery #Video

Video: Insights into structure and sequence activity 

Signals Inventa is a next-generation data management system for the analysis of scientific results. PerkinElmer has released a video that explains how this platform works.   The video shares how Signals Inventa provides a faster way to help chemists gain insights into structure and sequence activity relationships… Read More

#News

#Drug discovery #Infectious diseases #Molecular Biology #Research

Researchers discover way to disarm potentially deadly Listeria bacteria 

University of Queensland researchers have discovered a way to block Listeria from making the proteins that allow bacteria to survive and multiply in immune cells, which can cause severe illness in pregnant women and people with compromised immune systems. The study has been published in the journal PLOS Pathogens. Read More

#News

#Drug discovery

This week in drug discovery (24-28 January) 

News round-up by DDW’s Megan Thomas for 24-28 January, 2022  From further Covid-19 developments to cancer and chronic pain studies, there is a lot to appreciate and get excited about in the drug discovery sector. DDW’s Megan Thomas has rounded up five stories that have stood out… Read More

#News

#Biopharmaceuticals #Drug discovery #R&D #Therapeutics

Sitting down with… Dr Michael Hayden, Prilenia Therapeutics

Listen to this article on the DDW Podcast: Dr Michael Hayden’s early encounters and experience with patients and families suffering from Huntington’s Disease has had a significant personal impact that shaped his career. As CEO of Prilenia Therapeutics, he tells Lu Rahman why he has dedicated his career… Read More

#Editor's Choice #Exclusive Content #News #Opinion

CRISPR gene editing
#3D modelling #CRISPR #DNA #Drug discovery #Gene editing #Genomics #Screening

CRISPR screening in the third dimension 

Listen to this article on the DDW Podcast: Rosie Bryan & Carlos le Sage, Horizon Discovery, explain how CRISPR-Cas9 technology has become a gold standard for functional genomics.  While efforts in the cancer genomics field have uncovered the mutational landscapes in tumours covering many types of cancer, the… Read More

#Editor's Choice #Exclusive Content #News

#Assays #Biotechnology #Drug discovery #Enzymes #TechNote

TechNote: Radioactivity assays for methyltransferase enzymes

In this free TechNote by SAMDI Tech, learn how the company’s radioactivity assays overcome key challenges in drug discovery by offering key solutions, including: Detecting low amounts of product with sensitive assays Generating data rapidly with high-throughput, 384-well capabilities Characterising potent inhibitors by benefiting from lower enzyme concentrations Learn… Read More

#News #Trending News

#Biochemistry #Drug discovery #Mass spectrometry / NMR

How ASMS offers more than seeing what sticks 

Listen to this article on the DDW Podcast: Dr. Zack Gurard-Levin, Chief Scientific Officer, SAMDI Tech, breaks down three critical components to consider to ensure a successful affinity selection mass spectrometry (ASMS) drug discovery programme.  The ability to rapidly identify small molecules that non-covalently bind to… Read More

#Editor's Choice #Exclusive Content #News